JP2023525280A5 - - Google Patents

Info

Publication number
JP2023525280A5
JP2023525280A5 JP2022567655A JP2022567655A JP2023525280A5 JP 2023525280 A5 JP2023525280 A5 JP 2023525280A5 JP 2022567655 A JP2022567655 A JP 2022567655A JP 2022567655 A JP2022567655 A JP 2022567655A JP 2023525280 A5 JP2023525280 A5 JP 2023525280A5
Authority
JP
Japan
Application number
JP2022567655A
Other languages
Japanese (ja)
Other versions
JP2023525280A (ja
JP7741817B2 (ja
JPWO2021224501A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/062237 external-priority patent/WO2021224501A1/en
Publication of JP2023525280A publication Critical patent/JP2023525280A/ja
Publication of JP2023525280A5 publication Critical patent/JP2023525280A5/ja
Publication of JPWO2021224501A5 publication Critical patent/JPWO2021224501A5/ja
Application granted granted Critical
Publication of JP7741817B2 publication Critical patent/JP7741817B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022567655A 2020-05-08 2021-05-07 環縮合2-ピリドン化合物、その調製方法、並びにグラム陽性菌が関与する疾患の治療及び/又は予防におけるそれらの使用 Active JP7741817B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE2050543 2020-05-08
SE2050543-4 2020-05-08
PCT/EP2021/062237 WO2021224501A1 (en) 2020-05-08 2021-05-07 Ring-fused 2-pyridone compounds, methods for preparation thereof and their use in the treatment and/or prevention of a disease involving gram-positive bacteria

Publications (4)

Publication Number Publication Date
JP2023525280A JP2023525280A (ja) 2023-06-15
JP2023525280A5 true JP2023525280A5 (https=) 2024-05-14
JPWO2021224501A5 JPWO2021224501A5 (https=) 2024-05-14
JP7741817B2 JP7741817B2 (ja) 2025-09-18

Family

ID=75888058

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022567655A Active JP7741817B2 (ja) 2020-05-08 2021-05-07 環縮合2-ピリドン化合物、その調製方法、並びにグラム陽性菌が関与する疾患の治療及び/又は予防におけるそれらの使用

Country Status (8)

Country Link
US (1) US12503476B2 (https=)
EP (1) EP4146659B1 (https=)
JP (1) JP7741817B2 (https=)
CN (1) CN115551869B (https=)
DK (1) DK4146659T3 (https=)
ES (1) ES3017588T3 (https=)
PL (1) PL4146659T3 (https=)
WO (1) WO2021224501A1 (https=)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6841559B1 (en) * 1999-11-19 2005-01-11 Washington University Of St. Louis Pyridinones to treat and prevent bacterial infections
WO2014185853A1 (en) 2013-05-14 2014-11-20 Quretech Bio Ab Compounds and methods for treatment of chlamydia infections
CN107074878B (zh) 2014-11-13 2019-12-24 快尔生物技术公司 2,3-二氢-噻唑并[3,2-a]吡啶-5-酮衍生物、其中间体及其作为抗细菌剂的用途
EP3439655B1 (en) * 2016-04-08 2021-03-03 Quretech Bio AB Ring-fused thiazolino 2-pyridones, methods for preparation thereof and their use in the treatment and/or prevention of tuberculosis
EP3638681A1 (en) * 2017-06-13 2020-04-22 Quretech Bio AB Ring-fused thiazolino 2-pyridones, methods for preparation thereof and their use in the treatment and/or prevention of a disease involving gram-positive bacteria
CN111246848A (zh) * 2017-10-05 2020-06-05 快尔生物技术公司 与抗结核药物组合的环稠和的噻唑并2-吡啶酮

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023011539A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)
BR102021016375A2 (https=)
BR102021016176A2 (https=)